Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kaitlyn C. Steinmiller"'
Autor:
Sridar Narayanan, Kunio Nakamura, Linda M. Griffith, James Bowen, George J. Hutton, Uday R. Popat, Hyunwoo Lee, Michael K. Racke, Robert A. Brown, Steven M. Devine, Richard A. Nash, Douglas L. Arnold, George E. Georges, Kaitlyn C. Steinmiller
Publikováno v:
Multiple sclerosis and related disorders. 54
Background Brain volume loss (BVL) is commonly observed after high-dose immunosuppression and autologous hematopoietic cell transplantation (HDIT/HCT) for treatment of multiple sclerosis (MS). To better understand the mechanisms of underlying BVL ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c59b5d1c01a3e2d8b08f67a1c5fa4b7
https://pubmed.ncbi.nlm.nih.gov/34284316
https://pubmed.ncbi.nlm.nih.gov/34284316
Autor:
Keith M. Sullivan, Linda M. Griffith, Kaitlyn C. Steinmiller, Shelly Heimfeld, Tomeka C. Granderson, Christine W. Czarniecki, Julia S. Goldstein, Richard A. Nash, Carolyn A. Keever-Taylor
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:1463-1472
To ensure comparable grafts for autologous hematopoietic cell transplantation (HCT) in the National Institute of Allergy and Infectious Diseases–sponsored Investigational New Drug protocols for multiple sclerosis (HALT-MS) and systemic sclerosis (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3b45c7a71367cf080190e325a7fffe
https://doi.org/10.1016/j.bbmt.2017.05.018
https://doi.org/10.1016/j.bbmt.2017.05.018
Autor:
Steven M. Devine, Linda M. Griffith, Paolo A. Muraro, Olaf Stüve, Annette Wundes, Michael K. Racke, Richard A. Nash, Kaitlyn C. Steinmiller, James Bowen, George E. Georges, Uday R. Popat, Mark H. Wener, George H. Kraft, George J. Hutton, Peter H. Sayre, Douglas L. Arnold, Harry Openshaw
Publikováno v:
Neurology
Objective:To evaluate the safety, efficacy, and durability of multiple sclerosis (MS) disease stabilization after high-dose immunosuppressive therapy (HDIT) and autologous hematopoietic cell transplantation (HCT).Methods:High-Dose Immunosuppression a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0284cdf5a12a7324ce3df46121982e
http://europepmc.org/articles/PMC5331868
http://europepmc.org/articles/PMC5331868
Autor:
Carolyn A, Keever-Taylor, Shelly, Heimfeld, Kaitlyn C, Steinmiller, Richard A, Nash, Keith M, Sullivan, Christine W, Czarniecki, Tomeka C, Granderson, Julia S, Goldstein, Linda M, Griffith
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(9)
To ensure comparable grafts for autologous hematopoietic cell transplantation (HCT) in the National Institute of Allergy and Infectious Diseases–sponsored Investigational New Drug protocols for multiple sclerosis (HALT-MS) and systemic sclerosis (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b5bf6818f0de1b78c10d742a72dd6d4
https://pubmed.ncbi.nlm.nih.gov/28602891
https://pubmed.ncbi.nlm.nih.gov/28602891